FREIBURG, Germany — The owners of Cytena GmbH (“Cytena”) have agreed to sell all Cytena shares to CELLINK AB (“CELLINK”) for a purchase price of 30.25M euros (“acquisition”). Through CELLINK’s complimentary technology offering cytena sees great synergies that will support and accelerate future growth of Cytena. An extended product offering and a stronger global presence are just some of […]

CELLINK AB (“CELLINK”) has entered an agreement with the owners of cytena GmbH (“cytena”) to acquire all cytena shares for a purchase price of 30.25M euros (“acquisition”). Through cytena’s complementary technology offering, CELLINK sees great synergies that will support future growth. cytena is the company CELLINK announced signing a LOI with in conjunction with raising capital in […]

The newest osmometer designed to meet complex bioprocessing needs NORWOOD, MA:  Advanced Instruments—an innovative developer of scientific and analytical instruments and related services for the biotech industry—announced the latest release to its biotech instrument portfolio, the OsmoTECH PRO Multi-Sample Micro-Osmometer. Testing osmolality is an essential parameter for process control and QC – just one of the […]

San Jose, Calif. – Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced the launch of the next generation of its FLIPR® Penta High-Throughput Cellular Screening System. The new FLIPR Penta system builds on the success of the industry-leading FLIPR® platform for monitoring of GPCRs and ion channels, offering a new high-speed […]

BRANFORD, Conn. — IsoPlexis, the leading life sciences company in the single-cell functional biology space, has installed its innovative IsoLight single cell cytokine detection system at the Karolinska Institute in Sweden, as part of its expansion into Europe. In addition, IsoPlexis launched its first European office in the UK. This launch marks a significant milestone for IsoPlexis as they seek to […]

Khosla Ventures leads Series A investment in human tissue engineering company Prellis, backing Prellis’ mission to create viable human tissue and organs for research and transplant IMAGE: PRELLIS STRUCTURE TRANSPLANTED ALONE IS SURROUNDED BY SINGLE CELL WALLED CAPILLARIES WITHIN TWO WEEKS OF TRANSPLANTATION INTO IMMUNOCOMPETENT MOUSE (LEFT). HUMAN TUMOR CELLS TRANSPLANTED IN PRELLIS STRUCTURES GROW RAPIDLY, […]

Khosla Ventures leads Series A investment in human tissue engineering company Prellis, backing Prellis’ mission to create viable human tissue and organs for research and transplant San Francisco, CA–Prellis Biologics today announced that Khosla Ventures has led an $8.7 million Series A investment in the company. The announcement comes as Prellis has reached major tissue engineering […]

Company enters exclusive agreement with Millennium Science Pty Ltd SAN DIEGO, Calif. — NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced an exclusive agreement with Millennium Science to distribute NanoCellect’s WOLF® Cell Sorter, N1 Single-Cell Dispenser, consumables and software in Australia and New Zealand. Millennium Science is […]

Freiburg, Germany – Cytena, the specialist for single-cell technologies, is continuing its growth with the establishment of its subsidiary Cytena Bioprocess Solutions in Taiwan. Cytena Bioprocess Solutions is developing an innovative technology, which enables considerable reductions in time and increases in efficiency for cell line development. “With the new R&D focused company, we want to further strengthen our global […]